Homechevron_rightCompanieschevron_rightDefinitive Healthcare Corp.

Definitive Healthcare Corp. (DH)

Vertical SaaS

SaaS Metrics & Investor Data — Q4 2025

Definitive Healthcare Corp. (DH) is a Vertical SaaS SaaS company with a market cap of N/A as of Q4 2025. The company trades at N/A EV/Revenue and has delivered -4.2% revenue growth year-over-year. With a gross margin of 76% and FCF margin of 15.3%, Definitive Healthcare Corp. scores 11 on the Rule of 40 — placing it in the below-median of public SaaS companies tracked by SaaSDB.

monitoringInvestor Metrics

Market Cap
N/A
Q4 2025
Enterprise Value
N/A
Q4 2025
Revenue (TTM)
$241.5M
Q4 2025
Revenue Growth YoY
-4.2%
Year-over-year
EV / Revenue
N/A
Enterprise Value multiple
P/S Ratio
N/A
Price-to-Sales
Gross Margin
75.9%
Gross profit margin
Operating Margin
-92.9%
Operating income margin

From the makers of SaaSDB

B

Want a Full Research Brief on Definitive Healthcare Corp.?

BriefStock runs real DCF, FCF yield, and P/E calculations from SEC filings — with 8-section research briefs updated after every earnings call.

View DH on BriefStock

Advertisement

rocket_launchFounder & Operator Metrics

Rule of 40
11.1
Revenue growth + FCF margin
FCF Margin
15.3%
Free cash flow margin
Gross Margin
75.9%
Gross profit margin

Not publicly disclosed by this company: NRR·Gross Retention·ARR·ARR Growth·CAC Payback

Insider Trading Activity

DateInsiderTitleTransactionSharesPriceValue
2026-04-03Form 4 — 0001193125-26-142181
2026-04-03Form 4 — 0001193125-26-142183
2026-03-03Form 4 — 0001193125-26-088137
2026-02-26Form 4 — 0001193125-26-077209
2026-02-26Form 4 — 0001193125-26-077183
2026-02-26Form 4 — 0001193125-26-077188
2026-02-26Form 4 — 0001193125-26-077200
2026-02-26Form 4 — 0001193125-26-077194
2026-02-03Form 4 — 0001193125-26-035552
2026-02-03Form 4 — 0001193125-26-035486

Analyst Ratings

No analyst ratings available.

From the makers of SaaSDB

Go deeper with BriefStock

SaaSDB shows you the benchmarks. BriefStock shows you whether the stock is fairly valued — with automated earnings transcripts, insider signal analysis, and institutional 13-F tracking.

Try BriefStock Free